- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-9378
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
c-Met inhibitors ; volume:8 ; number:1 ; day:8 ; month:4 ; year:2013 ; pages:1-2 ; date:12.2013
Infectious agents and cancer ; 8, Heft 1 (8.4.2013), 1-2, 12.2013
- Urheber
-
Mughal, Anum
- Beteiligte Personen und Organisationen
-
Aslam, Hafiz Muhammad
Sheikh, Asfandyar
Khan, Agha Muhammad Hammad
Saleem, Shafaq
SpringerLink (Online service)
- DOI
-
10.1186/1750-9378-8-13
- URN
-
urn:nbn:de:1111-2016072626358
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mughal, Anum
- Aslam, Hafiz Muhammad
- Sheikh, Asfandyar
- Khan, Agha Muhammad Hammad
- Saleem, Shafaq
- SpringerLink (Online service)
Ähnliche Objekte (12)
Efficacy of c-Met inhibitor for advanced prostate cancer
The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
A selective c-Met and Trks inhibitor Indo5 suppresses hepatocellular carcinoma growth
Genstatus von PTEN und c-Met in Speicheldrüsenkarzinomen
Genstatus von PTEN und c-Met in Speicheldrüsenkarzinomen
Inhibition of phosphorylated c-Met in rhabdomyosarcoma cell lines by a small molecule inhibitor SU11274
89Zr-Onartuzumab PET imaging of c-MET receptor dynamics
Aptamers Binding to c-Met Inhibiting Tumor Cell Migration
Design, synthesis and biological evaluation of 6‐substituted quinolines derived from cabozantinib as c‐Met inhibitors
Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells
c-Met is expressed by highly autoreactive encephalitogenic CD8+ cells
c-Met als prognostischer Biomarker im EGFR-mutierten nichtkleinzelligen Lungenkarzinom
Efficacy of c-Met inhibitor for advanced prostate cancer
The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
A selective c-Met and Trks inhibitor Indo5 suppresses hepatocellular carcinoma growth
Genstatus von PTEN und c-Met in Speicheldrüsenkarzinomen
Genstatus von PTEN und c-Met in Speicheldrüsenkarzinomen
Inhibition of phosphorylated c-Met in rhabdomyosarcoma cell lines by a small molecule inhibitor SU11274
89Zr-Onartuzumab PET imaging of c-MET receptor dynamics
Aptamers Binding to c-Met Inhibiting Tumor Cell Migration
Design, synthesis and biological evaluation of 6‐substituted quinolines derived from cabozantinib as c‐Met inhibitors
Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells
c-Met is expressed by highly autoreactive encephalitogenic CD8+ cells
c-Met als prognostischer Biomarker im EGFR-mutierten nichtkleinzelligen Lungenkarzinom
Efficacy of c-Met inhibitor for advanced prostate cancer
The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
A selective c-Met and Trks inhibitor Indo5 suppresses hepatocellular carcinoma growth
Genstatus von PTEN und c-Met in Speicheldrüsenkarzinomen
Genstatus von PTEN und c-Met in Speicheldrüsenkarzinomen
Inhibition of phosphorylated c-Met in rhabdomyosarcoma cell lines by a small molecule inhibitor SU11274
89Zr-Onartuzumab PET imaging of c-MET receptor dynamics
Aptamers Binding to c-Met Inhibiting Tumor Cell Migration
Design, synthesis and biological evaluation of 6‐substituted quinolines derived from cabozantinib as c‐Met inhibitors
Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells
c-Met is expressed by highly autoreactive encephalitogenic CD8+ cells